Drugs / ASA
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04229264 Background | Jan 2020 → Feb 2022 | limb ischemia | Science Valley Research Institute | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04229264 ↗ |
| Route | Oral | “Aspirin 100 mg (oral, once-daily) for 1 year plus Clopidogrel 75 mg (oral, once-daily) for 3 months” NCT04229264 ↗ |